A carregar...
Repositioning rifamycins for Mycobacterium abscessus lung disease
INTRODUCTION: The treatment of Mycobacterium abscessus lung disease faces significant challenges due to intrinsic antibiotic resistance. New drugs are needed to cure this incurable disease. The key anti-tubercular rifamycin, rifampicin, suffers from low potency against M. abscessus and is not used c...
Na minha lista:
| Publicado no: | Expert Opin Drug Discov |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6663560/ https://ncbi.nlm.nih.gov/pubmed/31195849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17460441.2019.1629414 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|